A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...

Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

Dr. David Perlin, one of the world's top experts on fungi, spoke exclusively to the Record about a new variant of the ...

Florida lawmakers will convene a special session on Monday. Democratic Senator Rosalind Osgood said she agrees that something ...

Migrant facility Los Reales follow up ...

The European Commission is investing in a groundbreaking quantum chip that will use Germanium-Silicon (GeSi) to combine light ...

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

So the two key questions in protease-based drug discovery are: how specific should an inhibitor be to deliver a therapeutic outcome and what are the best ways to achieve the specificity needed?

Sons of Ecstasy takes a deep dive into Arizona's 1990s drug scene Shaun Attwood and Gerard Gravano battle for control of the ecstasy Documentary brings first-hand accounts from key players in the ...

"Furthermore, the production of this drug is invariably accompanied by wider criminality and the organised criminals behind them bring nothing but problems for our neighbourhoods. I’d like to ...